Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-25-000301
Filing Date
2025-04-14
Accepted
2025-04-14 16:24:52
Documents
78
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q aagh10q123124.htm   iXBRL 10-Q 907546
2 EXHIBIT 31.1 aaghex31-1.htm EX-31.1 13307
3 EXHIBIT 31.2 aaghex31-2.htm EX-31.2 13529
4 EXHIBIT 32.1 aaghex32-1.htm EX-32.1 4856
5 EXHIBIT 32.2 aaghex32-2.htm EX-32.2 4919
  Complete submission text file 0001185185-25-000301.txt   5845549

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aagh-20241231.xsd EX-101.SCH 57961
7 XBRL CALCULATION FILE aagh-20241231_cal.xml EX-101.CAL 35923
8 XBRL DEFINITION FILE aagh-20241231_def.xml EX-101.DEF 253147
9 XBRL LABEL FILE aagh-20241231_lab.xml EX-101.LAB 429568
10 XBRL PRESENTATION FILE aagh-20241231_pre.xml EX-101.PRE 272872
81 EXTRACTED XBRL INSTANCE DOCUMENT aagh10q123124_htm.xml XML 743002
Mailing Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803
Business Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803 (888) 988-1333
America Great Health (Filer) CIK: 0001098009 (see all company filings)

EIN.: 980178621 | State of Incorp.: CA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-27873 | Film No.: 25836324
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)